Press Coverage

Cellvizio Technology Helps Detect Precancerous Cells

10 October 2018

Read the full article on "Dr. Stephen Matter M.D. in Normal, Illinois using a fairly new technology to detect and diagnose precancerous conditions in the esophagus. He treats patients with chronic heartburn, acid reflux and indigestion caused by stomach acid getting into the esophagus."

Latest News

Mauna Kea Technologies announces entrance into exclusive negotiations for a licensing agreement for Cellvizio® in an important therapeutic area with a major industry player 

Mauna Kea Technologies announces entrance into exclusive negotiations for a licensing agreement for Cellvizio® in an important therapeutic area with a major industry player 

Mauna Kea Technologies announces the opening of a safeguard proceeding to restructure its financial liabilities 

Mauna Kea Technologies announces the opening of a safeguard proceeding to restructure its financial liabilities 

Cellvizio® Now Recommended in New European Society of Gastrointestinal Endoscopy Technical Guideline for Pancreatic Cyst Diagnosis

Cellvizio® Now Recommended in New European Society of Gastrointestinal Endoscopy Technical Guideline for Pancreatic Cyst Diagnosis